These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23684830)

  • 81. Microneedles: a valuable physical enhancer to increase transdermal drug delivery.
    Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Molina-Trinidad E; Casas-Alancaster N; Revilla-Vázquez AL
    J Clin Pharmacol; 2011 Jul; 51(7):964-77. PubMed ID: 21148047
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization.
    Andrianov AK; DeCollibus DP; Gillis HA; Kha HH; Marin A; Prausnitz MR; Babiuk LA; Townsend H; Mutwiri G
    Proc Natl Acad Sci U S A; 2009 Nov; 106(45):18936-41. PubMed ID: 19864632
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [From basic principles to clinical applications on transcutaneous vaccine].
    Okada N
    Yakugaku Zasshi; 2013; 133(12):1363-72. PubMed ID: 24292185
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Fluid absorption by skin tissue during intradermal injections through hollow microneedles.
    Shrestha P; Stoeber B
    Sci Rep; 2018 Sep; 8(1):13749. PubMed ID: 30213982
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Transcutaneous vaccination via laser microporation.
    Weiss R; Hessenberger M; Kitzmüller S; Bach D; Weinberger EE; Krautgartner WD; Hauser-Kronberger C; Malissen B; Boehler C; Kalia YN; Thalhamer J; Scheiblhofer S
    J Control Release; 2012 Sep; 162(2):391-9. PubMed ID: 22750193
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Influenza intradermal vaccine (soluble microneedles): A patch, a solution….
    Trilla A
    Med Clin (Barc); 2018 Apr; 150(8):307-309. PubMed ID: 29089121
    [No Abstract]   [Full Text] [Related]  

  • 87. Microneedle-mediated delivery of viral vectored vaccines.
    Zaric M; Ibarzo Yus B; Kalcheva PP; Klavinskis LS
    Expert Opin Drug Deliv; 2017 Oct; 14(10):1177-1187. PubMed ID: 27591122
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Delivery of antigens used for vaccination: recent advances and challenges.
    Scherliess R
    Ther Deliv; 2011 Oct; 2(10):1351-68. PubMed ID: 22826888
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Egg microneedles for transdermal vaccination of inactivated influenza virus.
    Kang G; Kim M; Lee Y; Yang H; Seong BL; Jung H
    Biomater Sci; 2024 Feb; 12(4):907-918. PubMed ID: 38174731
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Intradermal delivery of vaccines: potential benefits and current challenges.
    Hickling JK; Jones KR; Friede M; Zehrung D; Chen D; Kristensen D
    Bull World Health Organ; 2011 Mar; 89(3):221-6. PubMed ID: 21379418
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A needle-free approach for topical immunization: antigen delivery via vesicular carrier system(s).
    Mahor S; Gupta PN; Rawat A; Vyas SP
    Curr Med Chem; 2007; 14(27):2898-910. PubMed ID: 18045135
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity.
    Depelsenaire ACI; Meliga SC; McNeilly CL; Pearson FE; Coffey JW; Haigh OL; Flaim CJ; Frazer IH; Kendall MAF
    J Invest Dermatol; 2014 Sep; 134(9):2361-2370. PubMed ID: 24714201
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Skin thickness measurements for optimal intradermal injections in children.
    Van Mulder TJS; Van Nuffel D; Demolder M; De Meyer G; Moens S; Beyers KCL; Vankerckhoven VVJ; Van Damme P; Theeten H
    Vaccine; 2020 Jan; 38(4):763-768. PubMed ID: 31767463
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Micro-fractional Epidermal Powder Delivery for Skin Vaccination.
    Jia F; Liu S; Wu MX; Chen X
    Methods Mol Biol; 2016; 1404():715-723. PubMed ID: 27076332
    [TBL] [Abstract][Full Text] [Related]  

  • 95. An update on the use of laser technology in skin vaccination.
    Chen X; Wang J; Shah D; Wu MX
    Expert Rev Vaccines; 2013 Nov; 12(11):1313-23. PubMed ID: 24127871
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Are there differences in immune responses following delivery of vaccines through acutely or chronically sun-exposed compared with sun-unexposed skin?
    Hart PH; Norval M
    Immunology; 2020 Feb; 159(2):133-141. PubMed ID: 31593303
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Transcutaneous antigen delivery system.
    Lee MY; Shin MC; Yang VC
    BMB Rep; 2013 Jan; 46(1):17-24. PubMed ID: 23351379
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Tailored immunity by skin antigen-presenting cells.
    Levin C; Perrin H; Combadiere B
    Hum Vaccin Immunother; 2015; 11(1):27-36. PubMed ID: 25483512
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Microneedle-Mediated Vaccination: Innovation and Translation.
    Sheng T; Luo B; Zhang W; Ge X; Yu J; Zhang Y; Gu Z
    Adv Drug Deliv Rev; 2021 Dec; 179():113919. PubMed ID: 34375682
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Transdermal immunization: biological framework and translational perspectives.
    Mishra DK; Dhote V; Mishra PK
    Expert Opin Drug Deliv; 2013 Feb; 10(2):183-200. PubMed ID: 23256860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.